ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,283, issued on Sept. 29, was assigned to Takeda Vaccines Inc. (Cambridge, Mass.).
"Dengue vaccine unit dose and administration thereof" was invented by Derek Wallace (Brookline, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a single unit dose of a dengue vaccine composition and methods and uses for preventing dengue disease and methods for stimulating an immune response to all four dengue virus serotypes in a subject or subject population. The unit dose of a dengue vaccine composition includes constructs of each dengue serotype, such as TDV-1, TDV-2, TDV-3 and TDV-4, at various concentrations in order to improve prot...